...
search icon
lung-img

Pulmonx Corp Share Price

LUNG
NSQ
$1.47
+$0.05
(3.52%)
1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Pulmonx Corp Analyst Forecast

Pulmonx Corp Share Price Chart

Pulmonx Corp Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$58.57M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
250.58K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.07
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.31 L
$9.37 H
$1.47

About Pulmonx Corp, Common Stock

Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with multiple products, such as LungTraX Connect to improve workup efficiency; LungTraX Detect to enable patient identification; and StratX Lung report that is designed for solution that includes information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Pulmonx Corp Stock Returns

Time FrameLUNGSectorS&P500
1-Week Return-2%-1.08%-1.38%
1-Month Return-24.62%-0.47%-1.81%
3-Month Return-7.55%2.13%1.38%
6-Month Return-4.55%17.04%5.68%
1-Year Return-80.08%6.56%11.74%
3-Year Return-83.54%16.78%65.15%
5-Year Return-97.49%34.34%73.68%
10-Year Return-96.26%137.88%260.03%

Pulmonx Corp Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue32.73M48.42M53.66M68.67M83.79M[{"date":"2020-12-31","value":39.07,"profit":true},{"date":"2021-12-31","value":57.78,"profit":true},{"date":"2022-12-31","value":64.04,"profit":true},{"date":"2023-12-31","value":81.96,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue11.53M12.79M13.80M17.92M21.79M[{"date":"2020-12-31","value":52.92,"profit":true},{"date":"2021-12-31","value":58.68,"profit":true},{"date":"2022-12-31","value":63.32,"profit":true},{"date":"2023-12-31","value":82.26,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit21.20M35.63M39.87M50.75M62.00M[{"date":"2020-12-31","value":34.2,"profit":true},{"date":"2021-12-31","value":57.47,"profit":true},{"date":"2022-12-31","value":64.3,"profit":true},{"date":"2023-12-31","value":81.86,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin64.77%73.59%74.29%73.90%74.00%[{"date":"2020-12-31","value":87.19,"profit":true},{"date":"2021-12-31","value":99.06,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":99.48,"profit":true},{"date":"2024-12-31","value":99.61,"profit":true}]
Operating Expenses53.53M82.93M98.50M112.69M119.70M[{"date":"2020-12-31","value":44.72,"profit":true},{"date":"2021-12-31","value":69.28,"profit":true},{"date":"2022-12-31","value":82.29,"profit":true},{"date":"2023-12-31","value":94.14,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(32.33M)(47.30M)(58.64M)(61.94M)(57.70M)[{"date":"2020-12-31","value":-3233200000,"profit":false},{"date":"2021-12-31","value":-4730400000,"profit":false},{"date":"2022-12-31","value":-5863700000,"profit":false},{"date":"2023-12-31","value":-6193500000,"profit":false},{"date":"2024-12-31","value":-5770400000,"profit":false}]
Total Non-Operating Income/Expense(2.65M)(1.44M)530.00K3.75M3.36M[{"date":"2020-12-31","value":-70.74,"profit":false},{"date":"2021-12-31","value":-38.46,"profit":false},{"date":"2022-12-31","value":14.13,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":89.66,"profit":true}]
Pre-Tax Income(32.02M)(48.32M)(58.57M)(60.27M)(55.89M)[{"date":"2020-12-31","value":-3201800000,"profit":false},{"date":"2021-12-31","value":-4831800000,"profit":false},{"date":"2022-12-31","value":-5857000000,"profit":false},{"date":"2023-12-31","value":-6027200000,"profit":false},{"date":"2024-12-31","value":-5589400000,"profit":false}]
Income Taxes213.00K343.00K353.00K571.00K500.00K[{"date":"2020-12-31","value":37.3,"profit":true},{"date":"2021-12-31","value":60.07,"profit":true},{"date":"2022-12-31","value":61.82,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":87.57,"profit":true}]
Income After Taxes(32.23M)(48.66M)(58.92M)(60.84M)(56.39M)[{"date":"2020-12-31","value":-3223100000,"profit":false},{"date":"2021-12-31","value":-4866100000,"profit":false},{"date":"2022-12-31","value":-5892300000,"profit":false},{"date":"2023-12-31","value":-6084300000,"profit":false},{"date":"2024-12-31","value":-5639400000,"profit":false}]
Income From Continuous Operations(32.23M)(48.66M)(58.92M)(61.24M)(56.39M)[{"date":"2020-12-31","value":-3223100000,"profit":false},{"date":"2021-12-31","value":-4866100000,"profit":false},{"date":"2022-12-31","value":-5892300000,"profit":false},{"date":"2023-12-31","value":-6123800000,"profit":false},{"date":"2024-12-31","value":-5639400000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(32.23M)(48.66M)(58.92M)(60.84M)(56.39M)[{"date":"2020-12-31","value":-3223100000,"profit":false},{"date":"2021-12-31","value":-4866100000,"profit":false},{"date":"2022-12-31","value":-5892300000,"profit":false},{"date":"2023-12-31","value":-6084300000,"profit":false},{"date":"2024-12-31","value":-5639400000,"profit":false}]
EPS (Diluted)(7.57)(1.31)(1.59)(1.60)(1.40)[{"date":"2020-12-31","value":-757,"profit":false},{"date":"2021-12-31","value":-131,"profit":false},{"date":"2022-12-31","value":-159,"profit":false},{"date":"2023-12-31","value":-160,"profit":false},{"date":"2024-12-31","value":-140,"profit":false}]

Pulmonx Corp Ratios

Pulmonx Corp Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

LUNG
Cash Ratio 3.35
Current Ratio 4.86
Quick Ratio 4.15

Pulmonx Corp Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

LUNG
ROA (LTM) -23.38%
ROE (LTM) -73.73%

Pulmonx Corp Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

LUNG
Debt Ratio Lower is generally better. Negative is bad. 0.57
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.43

Pulmonx Corp Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

LUNG
Trailing PE NM
Forward PE 28.33
P/S (TTM) 0.64
P/B 1.00
Price/FCF NM
EV/R 0.44
EV/Ebitda NM

FAQs

What is Pulmonx Corp share price today?

Pulmonx Corp (LUNG) share price today is $1.47

Can Indians buy Pulmonx Corp shares?

Yes, Indians can buy shares of Pulmonx Corp (LUNG) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in LUNG stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Pulmonx Corp be purchased?

Yes, you can purchase fractional shares of Pulmonx Corp (LUNG) via the Vested app. You can start investing in Pulmonx Corp (LUNG) with a minimum investment of $1.

How to invest in Pulmonx Corp shares from India?

You can invest in shares of Pulmonx Corp (LUNG) via Vested in three simple steps:

  • Click on Sign Up or Invest in LUNG stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Pulmonx Corp shares
What is Pulmonx Corp 52-week high and low stock price?

The 52-week high price of Pulmonx Corp (LUNG) is $9.37. The 52-week low price of Pulmonx Corp (LUNG) is $1.31.

What is Pulmonx Corp price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Pulmonx Corp (LUNG) is

What is Pulmonx Corp price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Pulmonx Corp (LUNG) is 1.00

What is Pulmonx Corp dividend yield?

The dividend yield of Pulmonx Corp (LUNG) is 0.00%

What is the Market Cap of Pulmonx Corp?

The market capitalization of Pulmonx Corp (LUNG) is $58.57M

What is Pulmonx Corp's stock symbol?

The stock symbol (or ticker) of Pulmonx Corp is LUNG

How Can Investors Use Pulmonx Corp Share Price Data for Long-Term Investment Decisions?

Consider the share price of Pulmonx Corp as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Pulmonx Corp has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Pulmonx Corp shares for Indian investors?

When investing in Pulmonx Corp shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Pulmonx Corp stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Pulmonx Corp share price with other stocks in the same sector?

Rather than merely checking the share price of Pulmonx Corp and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Pulmonx Corp stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top